Rebecca Montes brings almost two decades of dietary supplement manufacturing experience and an established record of team leadership, quality improvement, increasing production efficiencies and regulatory compliance, innovation and major projects implementation. She is a veteran softgel manufacturer with her last 18 years at other Southern California based softgel facilities where she was responsible for the formulation process development and successful introduction of over 3000 products equating to over 1 billion dollars (retail) worth of product. The newly created role will position Ms. Montes as a key leader while Robinson Pharma Inc. (RPI) continues its fast-paced growth in both existing product capacity and its entrance into numerous new delivery systems, packaging formats, and business verticals.
Robinson Pharma Inc. has been experiencing very rapid growth, both from existing business lines and from acquisitions, most recently the asset purchase of Creations Garden Natural Products and Northridge Labs. RPI has already expanded into cosmetic and liquid products manufacturing, and has dramatically increased its powder processing capabilities. Additional leadership, specifically the skill set that Ms. Montes brings, is required to coordinate these new capabilities and manage the planned expansions of softgel production, hard shell encapsulation, and development of additional dose form manufacturing. Robinson Pharma Inc. is fully committed to a growth plan, underpinned by a commitment to quality, that will create additional new positions for the most capable people in the industry.
Robinson Pharma Inc. (RPI) is a minority-owned, Southern California based, full service-provider of private label, store brand, and contract manufacturing services for dietary supplements and pharmaceutical products. RPI has a drug manufacturing license and maintains more third party certifications for cGMP compliance than any other contract manufacturer with facility certifications from NPA, NSF and UL. RPI features the largest soft gel encapsulation capacity in the U.S. with 20 continuous dry encapsulation lines capable of producing over 12 billion soft gels per year and maintains 400,000 square feet of production, operations, and warehousing facilities. Production capabilities also include tablet compression, capsule filling, cosmetic products, liquid formulations, powder blending, enteric coating of soft gels and tablets, custom imprinting on softgels, and a range of packaging options including bottles, blister packaging, sachets, boxing, and bulk product. Additional services include product development and ingredient sourcing. RPI provides rapid turnaround on all projects and offers highly competitive pricing.
